Subject Matter Details
Grant, Contribution or Other Financial Benefit
- The client, Variation Biotechnologies Inc., has applied to the federal government for Strategic Innovation Fund grants to support development and manufacture of a vaccine against COVID-19 in Canada.
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Innovation, Science and Economic Development Canada (ISED)
No government funding was received during the last completed financial year.
Client Contact Information
201-310 Hunt Club Road
Ottawa, ON K1V 1C1
Jeff Baxter, CEO
Parent Company Information
Variation Biotechnologies, Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Variation Biotechnologies, Inc. is not a coalition.
Person or Organization with a Direct Interest Beneficiary Information
The activities of Variation Biotechnologies, Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
- VBI Vaccines, Inc.
666 Burrard St #1700,
Vancouver, BC V6C 2X8
No public offices held
96 Belleview Drive
Ottawa, ON K2L 1W3